Figure 7. CircCCDC66 promotes cell progression via FOXM1 and miR-320a pathways in glioma. (A) CCK-8 assays were used to evaluate cell viability after transfection in U373 cells. (B, C) Transwell assays of SW13783 and U373 cells after transfection. *P < 0.05, **P < 0.01.